COMMUNIQUÉS West-GlobeNewswire

New Novartis Phase III data for brolucizumab demonstrate reliability of 12-week treatment interval

30/04/2018 - 22:06

Patients identified for brolucizumab 12-week treatment interval in Phase III HAWK and HARRIER trials had an 87% and 83% probability of successfully continuing on a 12-week interval through week 48 Predictability data [...]

miRagen Therapeutics to Participate in Upcoming Investor Conferences

30/04/2018 - 22:05

BOULDER, Colo., April 30, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today [...]

AxoGen, Inc. Reports 2018 First Quarter Financial Results

30/04/2018 - 22:05

Record Q1 Revenue of $17.3 million, representing 41% growth over prior year ALACHUA, Fla., April 30, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical [...]

Eloxx Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

30/04/2018 - 22:01

WALTHAM, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX ) today announced the completion of its previously announced underwritten public offering of 5,899,500 shares of its [...]

Avadel Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference

30/04/2018 - 22:01

DUBLIN, Ireland, April 30, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ), “Avadel” or “the Company,” today announced that Greg Divis, Chief Operating Officer, and Mike Kanan, Chief Financial [...]

Theratechnologies’ CEO and CFO to Attend Bloom Burton Healthcare Investor Conference in Toronto

30/04/2018 - 22:00

MONTREAL, April 30, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) is pleased to announce that Luc Tanguay, President and Chief Executive Officer will make a presentation at the 2018 [...]

Le chef de la direction et le chef de la direction financière assisteront à la conférence d’investisseurs Bloom Burton à Toronto

30/04/2018 - 22:00

MONTRÉAL, 30 avr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) est heureuse d’annoncer que Luc Tanguay, président et chef de la direction fera une présentation dans le cadre de la [...]

Apellis Pharmaceuticals Reports First Quarter 2018 Business Update and Financial Results

30/04/2018 - 22:00

- APL-2 in Geographic Atrophy (GA) and Paroxysmal Nocturnal Hemoglobinuria (PNH) On Track to Advance into Phase 3 Trials in 2H18 - - Cash Position of $152.9 Million at Quarter-End; April 2018 Public Offering Raised [...]

New Mexico Cannabis Program on Pace to Break $100 Million

30/04/2018 - 19:47

Enrollment up 46 percent, patient sales up only 27 percent, restrictions on supply dampens sales ALBUQUERQUE, N.M., April 30, 2018 (GLOBE NEWSWIRE) -- The New Mexico Medical Cannabis Program patient revenues from the [...]

Editas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the American Society of Gene & Cell Therapy Annual Meeting

30/04/2018 - 19:30

Oral presentation of tolerability and immunogenicity data from a study of EDIT-101 following subretinal injection in non-human primates CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ [...]

AB Science reports today its annual financials as of 31 December 2017 and provides an update on its activities

30/04/2018 - 18:40

Paris, April 30, 2018 - 6.30pm 2017 revenues of 1,739 K€, an increase of 15.3% compared with 2016 Cash position of 38.8M€ as of 31 December 2017, plus 6.6M€ of 2017 tax credit to be reimbursed by the Public Finance [...]

AB Science annonce aujourd'hui ses résultats financiers annuels arrêtés au 31 décembre 2017 et présente l'actualité de ses activités

30/04/2018 - 18:40

Paris, le 30 avril 2018 - 18h30 Chiffre d'affaires de 1 739 K€ pour l'année 2017, en hausse de 15,3% par rapport à 2016 Trésorerie de 38,8M€ au 31 décembre 2017, à laquelle s'ajoutent 6,6M€ de crédit d'impôt 2017 en [...]

Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2018

30/04/2018 - 18:37

Bagsværd, Denmark, 30 April 2018 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of [...]

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2018 Annual Meeting

30/04/2018 - 18:15

Five oral presentations and 10 poster presentations focus on Voyager’s clinical and preclinical programs, novel capsid optimization efforts and manufacturing capabilities Investor and analyst breakfast event at ASGCT [...]

Report on Annual General Meeting of NeuroSearch A/S

30/04/2018 - 18:07

Announcement 30 April 2018 At the company’s Annual General Meeting held today, the following resolutions were passed: The Annual Report for 2017 was approved The Board of Directors' proposal regarding the transfer of [...]

Ossur Hf : Transactions in relation to share buyback program

30/04/2018 - 18:01

Announcement no. 33/2018 Reykjavik, 30 April 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

UPDATE – Imaging3 Announces Appointment of George Zdasiuk to Board of Directors

30/04/2018 - 17:32

Former CTO of Varian Medical Systems will also chair Imaging3 Scientific Advisory Board BURBANK, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Imaging 3 , Inc. (OTCQB:IGNG), a development stage company introducing [...]

CyberFuels Inc. Announces Major Expansion of US Retail Outlets for Gasoline and CyberFuels’ Proprietary EcoFlex Blends

30/04/2018 - 17:17

PALM BEACH GARDENS, Fla., April 30, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions Inc.'s (Pink sheets:ECSL) wholly owned subsidiary CyberFuels, Inc. is pleased to announce that CyberFuels has signed a contract with [...]

Amedisys Announces First Quarter Earnings Release and Conference Call Date

30/04/2018 - 17:00

BATON ROUGE, La., April 30, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), announced today that it will report results for the first quarter ended March 31, 2018 after the market closes on May 7, 2018. The [...]